Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.189NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.563NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.563NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.563NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.34NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.34NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.34NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.258NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.258NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.258NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.426NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.426NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.426NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.399NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.399NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.399NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.337NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.337NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.337NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.539NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.539NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.539NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.35NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.35NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.35NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.54NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.54NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.54NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.164NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.164NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.164NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KY.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KY.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.392NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.392NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.392NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.377NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.377NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.377NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.5.3 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.5.3 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.5.3 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BB.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BB.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BB.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.86 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used